WO2001060968A1 - Devices for motile sperm separation - Google Patents

Devices for motile sperm separation Download PDF

Info

Publication number
WO2001060968A1
WO2001060968A1 PCT/GB2001/000654 GB0100654W WO0160968A1 WO 2001060968 A1 WO2001060968 A1 WO 2001060968A1 GB 0100654 W GB0100654 W GB 0100654W WO 0160968 A1 WO0160968 A1 WO 0160968A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
spermatozoa
zone
vessel
motile
Prior art date
Application number
PCT/GB2001/000654
Other languages
French (fr)
Inventor
David Brickwood
Original Assignee
Genosis Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genosis Limited filed Critical Genosis Limited
Priority to AU3387201A priority Critical patent/AU3387201A/en
Priority to EP01905902A priority patent/EP1255810B1/en
Priority to AT01905902T priority patent/ATE283913T1/en
Priority to CA002399993A priority patent/CA2399993A1/en
Priority to JP2001560340A priority patent/JP4091767B2/en
Priority to US10/203,318 priority patent/US7179641B2/en
Priority to DE60107538T priority patent/DE60107538T2/en
Priority to AU2001233872A priority patent/AU2001233872B2/en
Publication of WO2001060968A1 publication Critical patent/WO2001060968A1/en
Priority to US11/324,257 priority patent/US20060110821A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0612—Germ cells sorting of gametes, e.g. according to sex or motility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Definitions

  • This invention is in the field of male fertility tests, more specifically tests for separating and detecting motile spermatozoa in a semen sample.
  • One such method is microscopic analysis, which is typically carried out in a hospital or commercial laboratory. More recently, however, a number of proposals have been made for test kits which are intended to simplify the detection of spermatozoa.
  • WO97/40386 discloses a kit which is based on immunodetection of the 34k ⁇ a human epididymal spermatozoa protein.
  • Spermatozoa in a sample are washed three times by centrifugation in Dulbecco-phosphate buffered saline. The samples are then heat denatured at 95°C, centrifuged at 14000g, and the supernatants are then used for analysis.
  • WO95/29188 describes a test based on antibodies to the SP- 10 antigen of human spermatozoa.
  • EP-A-0387873 discloses a kit which uses solid beads to which are bound antibody specific to the human spermatozoon acrosome.
  • the beads are mixed with a sample, incubated, separated, washed, and the number of spermatozoa bound to the beads is measured, preferably by examination with the aid of a microscope.
  • test kits do not distinguish between motile and non-motile spermatozoa. This distinction is the most predictive indicator of male infertility. Moreover, they involve procedures wh ⁇ ;h do not lend themselves to home use (e.g. centnfugation, microscopy), thus requiring implementation by a skilled practitioner.
  • WO00/09648 discloses an apparatus for separating motile spermatozoa from non-motile spermatozoa in a liquid sample
  • the apparatus comprising (I) a vessel having a sample receiving inlet, a filtered sample outlet and a sample separation filter mounted therebetween, the sample separation filter having a sample-receiving surface and an opposed surface, and the sample separation filter being effective substantially to prevent flow of the sample therethrough, but permitting passage of motile spermatozoa therethrough when said opposed surface of said sample separation filter is placed in contact with a liquid medium and ( ⁇ ) means for supplying a liquid to said opposed surface of said filter
  • the present invention provides a device for separating motile spermatozoa from a liquid sample, the device having a sample separation vessel comprising-
  • the separation medium in the vessel is initially prevented from flowing through the outlet port. This allows an incubation period which allows motile sperm sufficient time to migrate from the sample into the sample separation medium before it exits the vessel.
  • the outlet port is opened and the separation medium (including motile spermatozoa) can migrate through the outlet port and leave the vessel e.g for analysis
  • the inlet port and the separation medium In order for motile spermatozoa in the sample to enter the separation medium, the inlet port and the separation medium must be in liquid communication. Preferably, however, such communication is initially prevented, thus preventing contamination of the medium via the inlet port before the device is used This may also prevent the medium from escaping from the vessel via the inlet port, although this may be achieved anyway due to, for instance, viscosity or surface tension of the medium.
  • the vessel comprises (e) a second actuator, operable to bring the separation medium into communication with a sample via the inlet port.
  • a second actuator operable to bring the separation medium into communication with a sample via the inlet port. This might be achieved by storing the medium remotely from the inlet port until the second actuator is operated or, alternatively, by having an inlet port which is initially closed or sealed, which is opened using the actuator.
  • the second actuator is operated, thereby bringing the separation medium and the inlet port into communication. This allows motile spermatozoa in the sample to migrate from the sample into the separation medium.
  • the (first) actuator is operated, thereby allowing the separation medium (now containing motile spermatozoa) to leave the vessel. It is preferred that the first actuator cannot be operated until the second actuator has been operated.
  • feature (e) can operate independently from feature (d).
  • the vessel may be of circular cross-section e.g. conical or cylindrical.
  • the inlet and outlet ports can take a variety of forms.
  • the inlet port might be an open end of a cylinder or cone. This open end can be placed in a sample and, when the separation medium and the sample are in communication, spermatozoa can enter the vessel via the open end. It may be desirable to cover the open end by a mesh or grid, to assist in retaining sample separation medium within the vessel (via surface tension) without preventing the entry of spermatozoa from the sample.
  • the outlet port is preferably an opening, hole or aperture in the vessel ' s wall, which may continue into a pipe, tube or conduit leading away from the vessel.
  • the inlet and outlet ports are preferably arranged such that, during use, the outlet port is above the inlet port.
  • Spermatozoa thus have to swim against gravity in order to exit the vessel, enhancing the preferential migration of motile vs. non-motile sperm.
  • the (first) actuator is preferably a rotatable collar containing an opening. Rotation of the collar from a closed position aligns openings in the collar and vessel wall, thereby allowing sample separation medium to leave the vessel via the outlet port.
  • Another preferred form of (first) actuator acts to withdraw fluid into a barrel or tube e.g. it withdraws the plunger of a syringe. The plunger will initially block the outlet port but, on withdrawal of the plunger, sample separation medium can flow through the outlet port and into the internal space of the syringe.
  • a suitable actuator for effecting withdrawal of the syringe plunger is a rotatable knob which is attached to the plunger e.g. by a rack and pinion mechanism.
  • the device includes a second actuator
  • this is preferably a button.
  • sample separation medium stored within the device is released so that it reaches (e.g. by gravity) the inlet port.
  • This can be achieved by, for instance, including a reservoir of medium within the vessel, sealed by a foil wall, together with a foil cutter. Operation of the second actuator causes the cutter to pierce the foil, releasing the medium.
  • a preferred arrangement of reservoir is that disclosed in United Kingdom patent application 0021665.5, in which the separation medium is held within a hermetically sealed reservoir.
  • the device will include a venting needle for venting the medium from the reservoir, the venting needle comprising a fluid delivery portion and a reservoir- venting portion, the reservoir- venting portion being distal along the needle of the delivery portion, the delivery portion and the venting portion each defining a channel extending from the respective portion through the sidewall of the needle.
  • the channels allow the delivery portion, in use, to deliver fluid from the reservoir, for example by venting air at one end and dispensing fluid at the other.
  • the venting needle will preferably be at least partially a cannula having a cannulated point at the delivery portion for controlled, pipette-like delivery.
  • the distal portion may comprise both the venting portion and the delivery portion.
  • the needle preferably has a C-shaped section at the venting portion and the delivery portion.
  • the two channels are preferably unitary, the channel extending from the venting portion to the delivery portion.
  • the venting needle In a venting position, the venting needle preferably extends through two wall portions of the reservoir such that the venting portion forms a passage through the first wall portion to allow the container to be vented with air and the delivery portion forms a passage through the second wall portion to allow fluid to be dispensed from the reservoir.
  • the needle is operated by he second actuator (e.g. it is attached to a button or a screw-advance mechanism).
  • the separation medium allows motile spermatozoa, in preference to non-motile sperm, to migrate therethrough. This can be achieved using any suitable buffer (e.g. HEPES, EBSS etc.), as motile spermatozoa will be able to migrate through the medium actively whereas, over the relevant time-scale, non-motile spermatozoa will at best enter passively by diffusion. It is preferred, however, to use a medium that enhances the migration of motile spermatozoa from the sample. Suitable media include cervical mucus [e.g. Keel & Webster (1988) Fertil.
  • the medium may be in the form of a solution or a gel.
  • the separation medium also serves to 'wash' the sample, in order to remove components such as seminal plasma.
  • the device can detect motile spermatozoa after separation.
  • the device of the invention preferably comprises spermatozoa detection means in communication with the vessel outlet port.
  • the detection means may be integral with the device, or may be provided as a separate component for inserting into the device before, during or after sample separation.
  • the invention provides a device for separating and detecting motile spermatozoa in a liquid sample, the device having: - a sample separation vessel comprising:
  • a sample separation medium into which motile spermatozoa in the sample can migrate via the sample inlet port; and (d) an actuator operable to open the sample outlet port, thereby allowing the sample separation medium to flow out of the vessel through the sample outlet port, - spermatozoa detection means comprising:
  • an application zone in communication with the outlet port (i) an application zone in communication with the outlet port; (ii) a detection zone, in which the presence of spermatozoa can be detected; and (iii) a reagent zone containing a reagent which is capable of reacting with spermatozoa to facilitate their detection in the detection zone, these zones being arranged to permit capillary flow of spermatozoa from the application zone to the detection zone.
  • the detection zor.e is a zone past which spermatozoa cannot flow (a 'trapping zone'). During operation, flow of spermatozoa is thus prevented beyond the trapping zone, and sperm are immobilised for detection.
  • the trapping zone utilises the principles disclosed in WO00/20866 - the zone is porous with a pore size such that spermatozoa cannot enter. During flow into the trapping zone, therefore, sperm are captured at the entrance; as sperm concentration increases, the amount retained there also increases.
  • the trapping zone can be made from any suitable porous material (e.g. HDPR, nitrocellulose) through which spermatozoa cannot migrate. This requirement is reflected in the pore size of the trapping zone.
  • the head of a human spermatozoon is typically 3-5 ⁇ m in diameter, and tail length is approximately 50-60 ⁇ m.
  • the pore size should be selected accordingly (e.g. nitrocellulose, with a nominal pore size between 5-8 ⁇ m), and an appropriate pore size may be determined empirically by simple experimentation.
  • any porous material encountered before the trapping zone must, in contrast to the trapping zone, have a pore size large enough to allow spermatozoa to move relatively freely.
  • the nominal pore size of a porous material can be determined by hard particle challenge testing i.e. by determining the maximum diameter of spherical particles which can pass through the material.
  • the pore size of a material may be determined by measuring its 'bubble point'.
  • the bubble point is the pressure required to force air through a (water) wet membrane, and correlates with the pore size as measured by particle retention (although at extremes of pressure and pore size, the correlation may be weaker).
  • the bubble point is generally easier to measure than particle retention and is thus the preferred test when assessing pore size.
  • the entrance to the trapping zone is preferably narrow, such that sperm are focused to give a sharper signal.
  • immobilised anti-sperm antibody may be utilised.
  • detection is based on acrosin.
  • the detection zone will contain a reagent for detecting acrosin (e.g. see Mortimer, Practical Laboratory Andrology (1994), page 90) and the reagent zone will include a reagent such as proteinase K or the calcium ionophore A23187 [Perry et al. (1997) J.Exp.Zool. 279:284-290; Perry et al. (1997) J.Exp.Zool. 279:291-300 (1997); Perry et al. (1996) Human Reprod. 1 1 : 1055-1062; Perry et al. ( 1995) Fertil. Steril.
  • a preferred reagent for lysing acrosomes is a lysis buffer comprising 2% SDS, 100 ⁇ g/ml proteinase K in 10 mM Tris-HCl and 0.1 M EDTA. During migration, therefore, acrosin is released from the sperm and is detected downstream at the detection zone.
  • the reagent zone will contain a reagent which binds to intact spermatozoa or to one or more of the components thereof, and this binding reaction is used to generate a visual signal.
  • the reagent zone is a 'labelling zone', containing a label capable of binding to spermatozoa. This is preferably used in conjunction with a trapping zone.
  • the label within the labelling zone can be any suitable reagent that can bind to spermatozoa, preferably giving a visible signal. Because only motile spermatozoa will reach the outlet port, the label need not be specific for sperm.
  • the label is typically an antibody which can bind to spermatozoa and which has been suitably tagged. It is preferred to use a visible tag, such as colloidal gold (which is visible as a pink colour), although fluorescent, luminescent or radioactive tags can also be used. It will be appreciated that the term 'antibody' may include polyclonal and monoclonal antibodies, as well as antibody fragments (eg. F(ab) 2 . Fc etc.), provided that anti-sperm reactivity is retained.
  • a visible tag such as colloidal gold (which is visible as a pink colour)
  • fluorescent, luminescent or radioactive tags can also be used.
  • the term 'antibody' may include polyclonal and monoclonal antibodies, as well as antibody fragments (eg. F(ab) 2 . Fc etc.), provided that anti-sperm reactivity is retained.
  • Preferred labels recognise a surface antigen which is present on the majority of a population of spermatozoa, rather than a subset. Whilst any sperm antigen may be used (eg. P34H (WO97/40836), SP- 10 (WO95/29188), see also EP-A-0387873), 'universal' antigens such as CD59 may also used. As an alternative, a stain, such as eosin, may be used.
  • the label is not activated (e.g. re-hydration of dehydrated label) until sample separation medium leaves the vessel- This can be achieved by arranging the labelling zone such that label therein is not activated until the (first) actuator has been operated. Label therefore remains static until motile spermatozoa have left the sample and entered the sample separation medium.
  • the labelling zone may be arranged in any suitable position such that its label can contact spermatozoa in the detection zone (e.g. sperm retained at the trapping zone). It may be upstream or downstream of the application zone, or may be integral therewith. If it is upstream, sample separation medium leaving the vessel should be able to contact the labelling zone separately from its contact with the application zone, in order to activate the label; if it is downstream or integral, flow will automatically activate the label. Where the detection means includes both a 'trapping zone' and a 'labelling zone', the pore size of the trapping zone will be such that free label (not bound to spermatozoa) can flow therethrough, whereas label which is bound to spermatozoa cannot.
  • bound label is captured at the entrance.
  • the amount of capture label also increases. It will be apparent that the label must be smaller than spermatozoa, such that free label is not retarded by the trapping zone.
  • the detection means utilises a label
  • it preferably includes a zone downstream of the detection zone which retains unbound label (the 'label control' zone).
  • This will typically comprise immobilised antibody which can bind to unbound label (e.g. if the label is a murine monoclonal antibody, the label control zone may utilise anti-mouse antibody).
  • Label which passes through the detection zone e.g. which is not captured on entry to the trapping zone
  • a comparison of the amount of label in the detection zone and the label control zone allows semi-quantitative measurement of the amount of spermatozoa in the sample.
  • the application zone is where the sample separation medium leaving the vessel comes into contact with the spermatozoa detection means. It can be formed from any material suitable for allowing capillary flow of spermatozoa therethrough e.g. fibrous material, such as a pad of HDPE material, bonded polyester fibre, glass fibre, or the like.
  • spermatozoa tend to be retained within fibrous materials, thus reducing sensitivity. It is therefore preferred to use a non-fibrous application zone. Suitable examples include capillary tubes, the space between two or more sheets of material juxtaposed in close proximity such that capillary flow can occur therebetween, or a series of parallel capillary channels or grooves.
  • the labelling zone and the application zone are integral, this is preferably formed from more than one piece of material such that label can be applied during assembly. Where juxtaposed sheets are used, for instance, label can be applied to one or more sheets, and these can then be brought into proximity to permit capillary flow. Similarly, where parallel channels or grooves are used the label can be applied to the channelled material and, optionally, covered by a further sheet.
  • capillary flow takes place past a fibrous material rather than through it. Whilst flowing past, liquid can enter the fibrous material (e.g. to re-hydrate a label impregnated therein), but the main capillary flow through the application zone of sperm is not within the fibrous material.
  • the application zone and the sample outlet port may be essentially unitary.
  • flow of a sample to the detection zone is assisted by a downstream wick, to aid capillary movement.
  • the migration path of motile sperm in the sample is: entry to the separation medium via the vessel's inlet port, exit from the separation medium via the vessel's outlet port (upon operation of the actuator after an incubation period), entry to the application zone, and capillary flow to the trapping zone, in which further migration is prevented.
  • a visible signal at the trapping zone indicates the presence of motile spermatozoa in the sample
  • the visible signal provided by the detection means is preferably external to the vessel, and more preferably one which is also visible from the exterior of the device.
  • the detection means is preferably in the form of a lateral flow test strip mounted on the outside of the vessel.
  • the vessel may include more than one sample outlet port, each of which may lead to separate detection means. This allows independent tests on the same sample e.g. an assay for motile sperm on one strip and an assay for acrosome reaction on another strip. This can also be achieved by using a single outlet port that leads downstream to several separate detection means.
  • the device should be operated at an essentially fixed temperature. This will typically be between 30°C and 44°C, preferably between 35°C and 39°C, and more preferably fixed at or around 37°C. Preferably, therefore, the device includes a temperature sensor.
  • the temperature sensor may give a simple signal to indicate when operating temperature has been reached.
  • the device could be held in a user's hand, or inserted in a heated water bath, until the signal is given.
  • the device also includes its own heat source, which can preferably be regulated e.g. using thermostatic control.
  • the heat source should supply heat primarily to the region of the vessel wh ch contains the sample separation medium.
  • Power and control circuitry for the heat sourct may conveniently be concealed within an actuator button, or within the body of the device.
  • temperature regulation in the device can operate independently from the device's other features.
  • the device of the invention may be used with any suitable liquid sample, which is preferably a semen sample.
  • the device may include a receptacle for the sample. Preferably, this is in the form of a cup or sloping surface onto which a sample can be deposited, after which it collects at the base (e.g. in a well). The sample inlet can then be placed into contact with the collected sample.
  • the receptacle may also include an overflow near its base.
  • the receptacle may be integral with the device, or may be provided as a separate component to which the device may be attached before, during or after sample deposition and/or collection.
  • the interface between the receptacle and the vessel's inlet port is of a defined area, thereby aiding assay reproducibility.
  • the device of the invention can be produced simply and cheaply. Furthermore, it can be used very easily, for instance by the home user.
  • the invention thus provides an assay device which can be used at home as a basic screen of, for instance, male fertility.
  • the invention also provides corresponding processes.
  • the invention provides a process for separating motile spermatozoa from a liquid sample, the process comprising the steps of: (a) providing a vessel having a sample inlet port, a closed sample outlet port, and a sample separation medium;
  • the process may initially comprise the step of opening the inlet port.
  • the process also comprises steps for detecting spermatozoa in the medium once it has exited the vessel.
  • the invention provides a process for separating and detecting motile spermatozoa in a liquid sample, comprising the further steps of: (i) allowing sample separation medium that leaves the outlet port to flow by capillary action into material capable of immobilising spermatozoa; (ii) contacting spermatozoa with a label; and (iii) detecting label that is retained at the entrance to said material.
  • the invention further provides a process for separating and/or detecting spermatozoa, wherein sperm flow by capillary action takes place through non-fibrous material.
  • the invention further provides a process for separating motile and non-motile spermatozoa, wherein said process takes place at an essentially fixed temperature, preferably around 37°C.
  • Figure 1 shows a device according to the invention.
  • Figure 2 shows this device after insertion into a receptacle.
  • Figures 3 to 6 show the operation of this device.
  • Figure 7 shows an overview of using this device.
  • Figure 8 shows a second device according to the invention, prior to operation.
  • Figure 9 shows the same device separated into its two constituent pieces, with Figure 10 showing an exploded view of the top piece.
  • Figure 11 shows the construction of the test strip assembly used in the device.
  • Figures 12 to 16 show an overview of using this device.
  • the device (10) shown in Figure 1 comprises: a cylindrical plastic vessel (15); a sample inlet port (20), covered by a nylon mesh (21 ) formed from 0.15mm strands spaced by 0.25mm; a hole (30) in its side, shown in the open position; a solution (40) of EBSS supplemented with 0.88mg/ml hyaluronic acid and 0.45% BSA; a plastic rotatable collar (50), including a hole (51) which is shown aligned with hole (30) to form an outlet port (35); a button (60, shown depressed), which houses a battery and circuitry for powering a circumferential heat source (70) and attached to which is a solution reservoir (65, shown empty), a foil seal (66, shown broken), and a hollow foil cutter (68); and an externally mounted test strip (80).
  • Figure 2 shows the Figure 1 device ( 10) attached to a semen receptacle (90) with sloped walls.
  • a semen sample ( 100) has collected in the well (99) at the base of the receptacle (90), but some of it has overflowed into the receptacle overflow (95).
  • FIG 3 shows the device (10) immediately prior to use.
  • a semen sample (100) has collected in the well (99) and is in contact with the inlet port (20).
  • the outlet port (35) is closed because the hole (51) in the collar (50) is not aligned with the hole (30) in the vessel wall.
  • Solution (40) is held in reservoir (65) by foil seal (66), away from the inlet port (20).
  • button (60) is depressed, as shown in Figure 4A.
  • Foil cutter (68) pierces seal (66), releasing solution (40).
  • Motile sperm in the sample (100) are now in liquid communication with solution (40) and are able to migrate into it through the inlet (20), as shown in Figure 4B, whereas non-motile sperm and seminal plasma remain in sample (100).
  • Button (60) also activates heat source (70), bringing the temperature of solution (40) to 37°C.
  • the solution flows by capillary action through closely-juxtaposed plastic strips (81a & b) at the base of the test strip (80). Between the strips (81a & b) is an area (82) of dehydrated gold-labelled murine anti-CD59. As the solution passes area (82) between the strips (8 la & b), the antibody is re-hydrated and is able to bind to spermatozoa in the solution. Further downstream, the solution reaches nitrocellulose strip (83). The pore size of the strip (83) is too small to allow the spermatozoa to enter, so they are captured at its entrance (84). Free label continues to flow until it is captured downstream at a line (85) of immobilised anti-mouse antibody.
  • the device (1 10) shown in Figures 8 and 9 comprises an upper piece (191) and a lower piece (190) which fit together.
  • the base of lower piece (190) contains a well (199) into which a semen sample (200) is deposited.
  • Upper piece (191) includes a recessed window (1 13), a button (160) and a rotatable knob (150). Knob (150) and button (160) are shaped such that knob (150) cannot be rotated until button (160) has beer depressed.
  • upper piece * 191 is formed from a top piece (192) which engages a seating (193).
  • button (160) On the bottom of button (160) is a needle (168) and, when button (160) is operated, needle (168) pierces reservoir (165) which, prior to operation, contains a solution (140) of EBSS supplemented with 0.88mg/ml hyaluronic acid and 0.45% BSA.
  • Reservoir (165) sits in plastic housing (166), which has a neck portion (1 15) and a head portion (120). The side of neck (1 15) contains a hole (130) which engages the tube portion (186) of test strip assembly (180).
  • head portion (120) is covered by a circular nylon mesh (121) formed from 0.15mm strands spaced by 0.25mm.
  • mesh (121) is in contact with sample (200) within well (199).
  • Knob (150) is attached via a rack and pinion mechanism to plunger (155) which, prior to use, passes through tube ( 186) and towards hole (130).
  • Seating ( 193) contains a battery (194) which powers heat source (170). When assembled, heat source (170) surrounds neck (1 15) circumferentially, except in the region of hole (130).
  • FIG. 1 Exploded and assembled views of test strip assembly (180) are shown in Figure 1 1.
  • tubular portion ( 186) communicates directly with hole (130) and, prior to use, plunger ( 155) engages and fills tube (186), thereby preventing liquid flow therethrough.
  • plunger (155) is withdrawn by operation of knob ( 150) in the direction of the arrow in Figure 1 1
  • tube (186) opens to form, together with hole ( 130), an outlet port (135) through which liquid can flow.
  • Tube ( 186) and plunger (155) therefore operate in the manner of syringe.
  • the antibody As liquid passes pad (182), the antibody is re-hydrated and can pass into the liquid, where it is able to bind to spermatozoa.
  • the liquid continues to flow towards and into nitrocellulose strip ( 183), aided by a wick ( 188).
  • the pore size of strip (183) is too small to allow the spermatozoa to enter, so they are captured at its entrance (184).
  • Antibody can bind captured spermatozoa at entrance ( 184) and form a pink line. Any free antibody continues to flow until it is captured downstream at a line (185) of immobilised anti-mouse antibody.
  • the device is used as illustrated in figures 12 to 16:
  • a semen sample (200; e.g. obtained by masturbation) is placed into lower piece (190) and collects in well (199) whilst lower piece (190) rests on a flat surface.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • External Artificial Organs (AREA)
  • Centrifugal Separators (AREA)

Abstract

Device (10, 110) for separating motile sperm from a sample (100, 200), comprising a vessel (15, 115) having an inlet port (20, 120), an outlet port (35, 135) which is initially closed, a medium (40, 140) into which motile sperm in the sample (100, 200) can migrate into the vessel (15, 115) via the inlet (20, 120), and an actuator (50, 150), the operation of which opens the outlet (35, 135), thereby allowing the medium (40, 140) to flow out of the vessel (15, 115) through the outlet (35, 135). The medium (40, 140) in the vessel (15, 115) is initially prevented from flowing through the outlet (35, 135), thus allowing an incubation period which allows motile sperm sufficient time to migrate from the sample (100, 200) into the medium (40, 140) before the medium (40, 140) leaves the vessel (35, 135). The device (10, 110) preferably comprises spermatozoa detection means in communication with the outlet. In devices for separating sperm, capillary flow takes place through non-fibrous material, such as the space between sheets (81a and 81b; 181a and 181b) of closely-juxtaposed material. A device for separating motile and non-motile sperm includes a temperature sensor, a heat source (70, 170) and, optionally, temperature regulation means.

Description

DEVICES FOR MOTILE SPERM SEPARATION
All documents cited herein are incorporated by reference in their entirety.
TECHNICAL FIELD
This invention is in the field of male fertility tests, more specifically tests for separating and detecting motile spermatozoa in a semen sample.
BACKGROUND ART
Approximately 15% of couples attempting to conceive fail to do so within one year of unprotected intercourse. Fertility specialists define these couples as being infertile. 40% of these cases result from male factors. In a substantial proportion of these, treatment is available to ameliorate or relieve the condition which leads to infertility.
Other conditions also exist in which it is desirable to test for the presence or otherwise of viable spermatozoa in a sample. For example, vasectomies are now frequently carried out as a method of contraception, but it is necessary to confirm that ejaculate is free of viable spermatozoa after the operation.
A number of methods exist for assessing the motility and number of spermatozoa in a sample. One such method is microscopic analysis, which is typically carried out in a hospital or commercial laboratory. More recently, however, a number of proposals have been made for test kits which are intended to simplify the detection of spermatozoa.
WO97/40386 discloses a kit which is based on immunodetection of the 34kϋa human epididymal spermatozoa protein. Spermatozoa in a sample are washed three times by centrifugation in Dulbecco-phosphate buffered saline. The samples are then heat denatured at 95°C, centrifuged at 14000g, and the supernatants are then used for analysis.
WO95/29188 describes a test based on antibodies to the SP- 10 antigen of human spermatozoa.
EP-A-0387873 discloses a kit which uses solid beads to which are bound antibody specific to the human spermatozoon acrosome. The beads are mixed with a sample, incubated, separated, washed, and the number of spermatozoa bound to the beads is measured, preferably by examination with the aid of a microscope.
A disadvantage of these test kits is that they do not distinguish between motile and non-motile spermatozoa. This distinction is the most predictive indicator of male infertility. Moreover, they involve procedures whι ;h do not lend themselves to home use (e.g. centnfugation, microscopy), thus requiring implementation by a skilled practitioner.
These disadvantages are addres >ed by the device of WO00/09648 (Genosis Limited), which discloses an apparatus for separating motile spermatozoa from non-motile spermatozoa in a liquid sample, the apparatus comprising (I) a vessel having a sample receiving inlet, a filtered sample outlet and a sample separation filter mounted therebetween, the sample separation filter having a sample-receiving surface and an opposed surface, and the sample separation filter being effective substantially to prevent flow of the sample therethrough, but permitting passage of motile spermatozoa therethrough when said opposed surface of said sample separation filter is placed in contact with a liquid medium and (π) means for supplying a liquid to said opposed surface of said filter
Further improvements in sperm separation, detection and analysis are disclosed herein
DISCLOSURE OF THE INVENTION
The present invention provides a device for separating motile spermatozoa from a liquid sample, the device having a sample separation vessel comprising-
(a) a sample inlet port,
(b) a sample outlet port, which is initially closed,
(c) a sample separation medium into which motile spermatozoa in the sample can migrate via the sample inlet port, and (d) an actuator operable to open the sample outlet port, thereby allowing the sample separation medium to flow out of the vessel through the sample outlet port
In this device, the separation medium in the vessel is initially prevented from flowing through the outlet port. This allows an incubation period which allows motile sperm sufficient time to migrate from the sample into the sample separation medium before it exits the vessel. On operation of the actuator, the outlet port is opened and the separation medium (including motile spermatozoa) can migrate through the outlet port and leave the vessel e.g for analysis
In order for motile spermatozoa in the sample to enter the separation medium, the inlet port and the separation medium must be in liquid communication. Preferably, however, such communication is initially prevented, thus preventing contamination of the medium via the inlet port before the device is used This may also prevent the medium from escaping from the vessel via the inlet port, although this may be achieved anyway due to, for instance, viscosity or surface tension of the medium.
In this embodiment, therefore, the vessel comprises (e) a second actuator, operable to bring the separation medium into communication with a sample via the inlet port. This might be achieved by storing the medium remotely from the inlet port until the second actuator is operated or, alternatively, by having an inlet port which is initially closed or sealed, which is opened using the actuator.
During use of this device, therefore, the second actuator is operated, thereby bringing the separation medium and the inlet port into communication. This allows motile spermatozoa in the sample to migrate from the sample into the separation medium. After a period of incubation, the (first) actuator is operated, thereby allowing the separation medium (now containing motile spermatozoa) to leave the vessel. It is preferred that the first actuator cannot be operated until the second actuator has been operated.
It will be appreciated that feature (e) can operate independently from feature (d).
The vessel may be of circular cross-section e.g. conical or cylindrical.
The inlet and outlet ports can take a variety of forms. For instance, the inlet port might be an open end of a cylinder or cone. This open end can be placed in a sample and, when the separation medium and the sample are in communication, spermatozoa can enter the vessel via the open end. It may be desirable to cover the open end by a mesh or grid, to assist in retaining sample separation medium within the vessel (via surface tension) without preventing the entry of spermatozoa from the sample.
The outlet port is preferably an opening, hole or aperture in the vessel's wall, which may continue into a pipe, tube or conduit leading away from the vessel.
The inlet and outlet ports are preferably arranged such that, during use, the outlet port is above the inlet port. Spermatozoa thus have to swim against gravity in order to exit the vessel, enhancing the preferential migration of motile vs. non-motile sperm.
Any suitable actuators can be used in the device e.g. buttons, switches etc. Where the vessel is of circular cross-section, the (first) actuator is preferably a rotatable collar containing an opening. Rotation of the collar from a closed position aligns openings in the collar and vessel wall, thereby allowing sample separation medium to leave the vessel via the outlet port. Another preferred form of (first) actuator acts to withdraw fluid into a barrel or tube e.g. it withdraws the plunger of a syringe. The plunger will initially block the outlet port but, on withdrawal of the plunger, sample separation medium can flow through the outlet port and into the internal space of the syringe. A suitable actuator for effecting withdrawal of the syringe plunger is a rotatable knob which is attached to the plunger e.g. by a rack and pinion mechanism.
Where the device includes a second actuator, this is preferably a button. When pressed, sample separation medium stored within the device is released so that it reaches (e.g. by gravity) the inlet port. This can be achieved by, for instance, including a reservoir of medium within the vessel, sealed by a foil wall, together with a foil cutter. Operation of the second actuator causes the cutter to pierce the foil, releasing the medium.
A preferred arrangement of reservoir is that disclosed in United Kingdom patent application 0021665.5, in which the separation medium is held within a hermetically sealed reservoir. The device will include a venting needle for venting the medium from the reservoir, the venting needle comprising a fluid delivery portion and a reservoir- venting portion, the reservoir- venting portion being distal along the needle of the delivery portion, the delivery portion and the venting portion each defining a channel extending from the respective portion through the sidewall of the needle. The channels allow the delivery portion, in use, to deliver fluid from the reservoir, for example by venting air at one end and dispensing fluid at the other. In this arrangement, the venting needle will preferably be at least partially a cannula having a cannulated point at the delivery portion for controlled, pipette-like delivery. In a needle with a proximal portion and a distal portion, the distal portion may comprise both the venting portion and the delivery portion. The needle preferably has a C-shaped section at the venting portion and the delivery portion. The two channels are preferably unitary, the channel extending from the venting portion to the delivery portion.
In a venting position, the venting needle preferably extends through two wall portions of the reservoir such that the venting portion forms a passage through the first wall portion to allow the container to be vented with air and the delivery portion forms a passage through the second wall portion to allow fluid to be dispensed from the reservoir.
Using this sort of arrangement, the needle is operated by he second actuator (e.g. it is attached to a button or a screw-advance mechanism). The separation medium allows motile spermatozoa, in preference to non-motile sperm, to migrate therethrough. This can be achieved using any suitable buffer (e.g. HEPES, EBSS etc.), as motile spermatozoa will be able to migrate through the medium actively whereas, over the relevant time-scale, non-motile spermatozoa will at best enter passively by diffusion. It is preferred, however, to use a medium that enhances the migration of motile spermatozoa from the sample. Suitable media include cervical mucus [e.g. Keel & Webster (1988) Fertil. Steril. 49: 138-143], polyacrylamide gel [e.g. Lorton et al. ( 1981 ) Fertil. Steril. 35:222-225], hyaluronic acid [e.g. Aitken et al. (1992) J. Androl. 13:44-54], or a cellulose derivative [e.g. international patent application PCT/GB00/03130 (Genosis Limited)] such as methylcellulose.
The medium may be in the form of a solution or a gel.
Advantageously, the separation medium also serves to 'wash' the sample, in order to remove components such as seminal plasma.
In addition to separating motile and non-motile spermatozoa, it is preferred that the device can detect motile spermatozoa after separation. Accordingly, the device of the invention preferably comprises spermatozoa detection means in communication with the vessel outlet port. The detection means may be integral with the device, or may be provided as a separate component for inserting into the device before, during or after sample separation.
Accordingly, the invention provides a device for separating and detecting motile spermatozoa in a liquid sample, the device having: - a sample separation vessel comprising:
(a) a sample inlet port;
(b) a sample outlet port, which is initially closed;
(c) a sample separation medium into which motile spermatozoa in the sample can migrate via the sample inlet port; and (d) an actuator operable to open the sample outlet port, thereby allowing the sample separation medium to flow out of the vessel through the sample outlet port, - spermatozoa detection means comprising:
(i) an application zone in communication with the outlet port; (ii) a detection zone, in which the presence of spermatozoa can be detected; and (iii) a reagent zone containing a reagent which is capable of reacting with spermatozoa to facilitate their detection in the detection zone, these zones being arranged to permit capillary flow of spermatozoa from the application zone to the detection zone. Preferably, the detection zor.e is a zone past which spermatozoa cannot flow (a 'trapping zone'). During operation, flow of spermatozoa is thus prevented beyond the trapping zone, and sperm are immobilised for detection. Preferably, the trapping zone utilises the principles disclosed in WO00/20866 - the zone is porous with a pore size such that spermatozoa cannot enter. During flow into the trapping zone, therefore, sperm are captured at the entrance; as sperm concentration increases, the amount retained there also increases.
The trapping zone can be made from any suitable porous material (e.g. HDPR, nitrocellulose) through which spermatozoa cannot migrate. This requirement is reflected in the pore size of the trapping zone. The head of a human spermatozoon is typically 3-5μm in diameter, and tail length is approximately 50-60μm. The pore size should be selected accordingly (e.g. nitrocellulose, with a nominal pore size between 5-8μm), and an appropriate pore size may be determined empirically by simple experimentation.
It will be apparent that any porous material encountered before the trapping zone must, in contrast to the trapping zone, have a pore size large enough to allow spermatozoa to move relatively freely.
As is well known to those in the art, the nominal pore size of a porous material can be determined by hard particle challenge testing i.e. by determining the maximum diameter of spherical particles which can pass through the material. Alternatively, the pore size of a material may be determined by measuring its 'bubble point'. The bubble point is the pressure required to force air through a (water) wet membrane, and correlates with the pore size as measured by particle retention (although at extremes of pressure and pore size, the correlation may be weaker). The bubble point is generally easier to measure than particle retention and is thus the preferred test when assessing pore size.
The entrance to the trapping zone is preferably narrow, such that sperm are focused to give a sharper signal.
As a less-preferred detection zone, immobilised anti-sperm antibody may be utilised.
In one embodiment of the detection zone, detection is based on acrosin. The detection zone will contain a reagent for detecting acrosin (e.g. see Mortimer, Practical Laboratory Andrology (1994), page 90) and the reagent zone will include a reagent such as proteinase K or the calcium ionophore A23187 [Perry et al. (1997) J.Exp.Zool. 279:284-290; Perry et al. (1997) J.Exp.Zool. 279:291-300 (1997); Perry et al. (1996) Human Reprod. 1 1 : 1055-1062; Perry et al. ( 1995) Fertil. Steril. 64: 150-159] which causes the acrosomes to open. A preferred reagent for lysing acrosomes is a lysis buffer comprising 2% SDS, 100 μg/ml proteinase K in 10 mM Tris-HCl and 0.1 M EDTA. During migration, therefore, acrosin is released from the sperm and is detected downstream at the detection zone.
More usually, the reagent zone will contain a reagent which binds to intact spermatozoa or to one or more of the components thereof, and this binding reaction is used to generate a visual signal. Preferably, therefore, the reagent zone is a 'labelling zone', containing a label capable of binding to spermatozoa. This is preferably used in conjunction with a trapping zone.
The label within the labelling zone can be any suitable reagent that can bind to spermatozoa, preferably giving a visible signal. Because only motile spermatozoa will reach the outlet port, the label need not be specific for sperm.
The label is typically an antibody which can bind to spermatozoa and which has been suitably tagged. It is preferred to use a visible tag, such as colloidal gold (which is visible as a pink colour), although fluorescent, luminescent or radioactive tags can also be used. It will be appreciated that the term 'antibody' may include polyclonal and monoclonal antibodies, as well as antibody fragments (eg. F(ab)2. Fc etc.), provided that anti-sperm reactivity is retained.
Preferred labels recognise a surface antigen which is present on the majority of a population of spermatozoa, rather than a subset. Whilst any sperm antigen may be used (eg. P34H (WO97/40836), SP- 10 (WO95/29188), see also EP-A-0387873), 'universal' antigens such as CD59 may also used. As an alternative, a stain, such as eosin, may be used.
It is preferred that the label is not activated (e.g. re-hydration of dehydrated label) until sample separation medium leaves the vessel- This can be achieved by arranging the labelling zone such that label therein is not activated until the (first) actuator has been operated. Label therefore remains static until motile spermatozoa have left the sample and entered the sample separation medium.
The labelling zone may be arranged in any suitable position such that its label can contact spermatozoa in the detection zone (e.g. sperm retained at the trapping zone). It may be upstream or downstream of the application zone, or may be integral therewith. If it is upstream, sample separation medium leaving the vessel should be able to contact the labelling zone separately from its contact with the application zone, in order to activate the label; if it is downstream or integral, flow will automatically activate the label. Where the detection means includes both a 'trapping zone' and a 'labelling zone', the pore size of the trapping zone will be such that free label (not bound to spermatozoa) can flow therethrough, whereas label which is bound to spermatozoa cannot. During flow into the trapping zone, therefore, bound label is captured at the entrance. As sperm concentration increases, the amount of capture label also increases. It will be apparent that the label must be smaller than spermatozoa, such that free label is not retarded by the trapping zone.
Where the detection means utilises a label, it preferably includes a zone downstream of the detection zone which retains unbound label (the 'label control' zone). This will typically comprise immobilised antibody which can bind to unbound label (e.g. if the label is a murine monoclonal antibody, the label control zone may utilise anti-mouse antibody). Label which passes through the detection zone (e.g. which is not captured on entry to the trapping zone) is thus retained within the label control zone, where it can be measured. A comparison of the amount of label in the detection zone and the label control zone allows semi-quantitative measurement of the amount of spermatozoa in the sample.
The application zone is where the sample separation medium leaving the vessel comes into contact with the spermatozoa detection means. It can be formed from any material suitable for allowing capillary flow of spermatozoa therethrough e.g. fibrous material, such as a pad of HDPE material, bonded polyester fibre, glass fibre, or the like.
It has been found, however, that spermatozoa tend to be retained within fibrous materials, thus reducing sensitivity. It is therefore preferred to use a non-fibrous application zone. Suitable examples include capillary tubes, the space between two or more sheets of material juxtaposed in close proximity such that capillary flow can occur therebetween, or a series of parallel capillary channels or grooves. In such arrangements, if the labelling zone and the application zone are integral, this is preferably formed from more than one piece of material such that label can be applied during assembly. Where juxtaposed sheets are used, for instance, label can be applied to one or more sheets, and these can then be brought into proximity to permit capillary flow. Similarly, where parallel channels or grooves are used the label can be applied to the channelled material and, optionally, covered by a further sheet.
In a similar arrangement, capillary flow takes place past a fibrous material rather than through it. Whilst flowing past, liquid can enter the fibrous material (e.g. to re-hydrate a label impregnated therein), but the main capillary flow through the application zone of sperm is not within the fibrous material.
The application zone and the sample outlet port may be essentially unitary.
In preferred embodiments, flow of a sample to the detection zone is assisted by a downstream wick, to aid capillary movement.
During use of preferred devices, therefore, the migration path of motile sperm in the sample is: entry to the separation medium via the vessel's inlet port, exit from the separation medium via the vessel's outlet port (upon operation of the actuator after an incubation period), entry to the application zone, and capillary flow to the trapping zone, in which further migration is prevented. A visible signal at the trapping zone indicates the presence of motile spermatozoa in the sample
The visible signal provided by the detection means is preferably external to the vessel, and more preferably one which is also visible from the exterior of the device.
The detection means is preferably in the form of a lateral flow test strip mounted on the outside of the vessel.
It will be appreciated that the vessel may include more than one sample outlet port, each of which may lead to separate detection means. This allows independent tests on the same sample e.g. an assay for motile sperm on one strip and an assay for acrosome reaction on another strip. This can also be achieved by using a single outlet port that leads downstream to several separate detection means.
To enhance the separation of motile and non-motile spermatozoa (e.g. EP-A-0437508), it is preferred that the device should be operated at an essentially fixed temperature. This will typically be between 30°C and 44°C, preferably between 35°C and 39°C, and more preferably fixed at or around 37°C. Preferably, therefore, the device includes a temperature sensor.
The temperature sensor may give a simple signal to indicate when operating temperature has been reached. The device could be held in a user's hand, or inserted in a heated water bath, until the signal is given.
More preferably, however, the device also includes its own heat source, which can preferably be regulated e.g. using thermostatic control. The heat source should supply heat primarily to the region of the vessel wh ch contains the sample separation medium. Power and control circuitry for the heat sourct may conveniently be concealed within an actuator button, or within the body of the device.
It will be appreciated that the inclusion of temperature regulation in the device can operate independently from the device's other features.
The device of the invention may be used with any suitable liquid sample, which is preferably a semen sample. The device may include a receptacle for the sample. Preferably, this is in the form of a cup or sloping surface onto which a sample can be deposited, after which it collects at the base (e.g. in a well). The sample inlet can then be placed into contact with the collected sample. The receptacle may also include an overflow near its base. The receptacle may be integral with the device, or may be provided as a separate component to which the device may be attached before, during or after sample deposition and/or collection.
Advantageously, the interface between the receptacle and the vessel's inlet port (e.g. where the vessel attaches to the well) is of a defined area, thereby aiding assay reproducibility.
The device of the invention can be produced simply and cheaply. Furthermore, it can be used very easily, for instance by the home user. The invention thus provides an assay device which can be used at home as a basic screen of, for instance, male fertility.
The invention also provides corresponding processes. Thus the invention provides a process for separating motile spermatozoa from a liquid sample, the process comprising the steps of: (a) providing a vessel having a sample inlet port, a closed sample outlet port, and a sample separation medium;
(b) allowing spermatozoa in the sample to migrate into the sample separation medium over a period of between 5 and 60 minutes (preferably around 30 minutes); and
(c) allowing the sample separation medium to leave the vessel by opening the sample outlet port.
The process may initially comprise the step of opening the inlet port.
Preferably, the process also comprises steps for detecting spermatozoa in the medium once it has exited the vessel. Thus the invention provides a process for separating and detecting motile spermatozoa in a liquid sample, comprising the further steps of: (i) allowing sample separation medium that leaves the outlet port to flow by capillary action into material capable of immobilising spermatozoa; (ii) contacting spermatozoa with a label; and (iii) detecting label that is retained at the entrance to said material.
The invention further provides a process for separating and/or detecting spermatozoa, wherein sperm flow by capillary action takes place through non-fibrous material.
The invention further provides a process for separating motile and non-motile spermatozoa, wherein said process takes place at an essentially fixed temperature, preferably around 37°C.
BRIEF DESCRIPTION OF DRAWINGS Figure 1 shows a device according to the invention. Figure 2 shows this device after insertion into a receptacle. Figures 3 to 6 show the operation of this device. Figure 7 shows an overview of using this device.
Figure 8 shows a second device according to the invention, prior to operation. Figure 9 shows the same device separated into its two constituent pieces, with Figure 10 showing an exploded view of the top piece. Figure 11 shows the construction of the test strip assembly used in the device. Figures 12 to 16 show an overview of using this device.
MODES FOR CARRYING OUT THE INVENTION
The device (10) shown in Figure 1 comprises: a cylindrical plastic vessel (15); a sample inlet port (20), covered by a nylon mesh (21 ) formed from 0.15mm strands spaced by 0.25mm; a hole (30) in its side, shown in the open position; a solution (40) of EBSS supplemented with 0.88mg/ml hyaluronic acid and 0.45% BSA; a plastic rotatable collar (50), including a hole (51) which is shown aligned with hole (30) to form an outlet port (35); a button (60, shown depressed), which houses a battery and circuitry for powering a circumferential heat source (70) and attached to which is a solution reservoir (65, shown empty), a foil seal (66, shown broken), and a hollow foil cutter (68); and an externally mounted test strip (80).
Figure 2 shows the Figure 1 device ( 10) attached to a semen receptacle (90) with sloped walls. A semen sample ( 100) has collected in the well (99) at the base of the receptacle (90), but some of it has overflowed into the receptacle overflow (95).
Figure 3 shows the device (10) immediately prior to use. A semen sample (100) has collected in the well (99) and is in contact with the inlet port (20). The outlet port (35) is closed because the hole (51) in the collar (50) is not aligned with the hole (30) in the vessel wall. Solution (40) is held in reservoir (65) by foil seal (66), away from the inlet port (20).
To initiate the test, button (60) is depressed, as shown in Figure 4A. Foil cutter (68) pierces seal (66), releasing solution (40). Motile sperm in the sample (100) are now in liquid communication with solution (40) and are able to migrate into it through the inlet (20), as shown in Figure 4B, whereas non-motile sperm and seminal plasma remain in sample (100). Button (60) also activates heat source (70), bringing the temperature of solution (40) to 37°C.
After a period of about 30 minutes, during which motile sperm have migrated into the solution (40), collar (50) is rotated, as shown in Figure 5, so that its hole (51) aligns with hole (30), thereby opening the outlet port (35). Solution (40), now containing motile sperm, is free to leave the vessel and contact externally-mounted test strip (80).
As shown in Figure 6, the solution flows by capillary action through closely-juxtaposed plastic strips (81a & b) at the base of the test strip (80). Between the strips (81a & b) is an area (82) of dehydrated gold-labelled murine anti-CD59. As the solution passes area (82) between the strips (8 la & b), the antibody is re-hydrated and is able to bind to spermatozoa in the solution. Further downstream, the solution reaches nitrocellulose strip (83). The pore size of the strip (83) is too small to allow the spermatozoa to enter, so they are captured at its entrance (84). Free label continues to flow until it is captured downstream at a line (85) of immobilised anti-mouse antibody.
As shown in Figure 7, entrance (84) and line (85) are visible through windows. In Figure 7E, two lines are visible, indicating the presence of motile spermatozoa in the original sample. In contrast, only the control line (85) is visible in Figure 7F, indicating an absence of motile sperm in the original sample.
The device (1 10) shown in Figures 8 and 9 comprises an upper piece (191) and a lower piece (190) which fit together. The base of lower piece (190) contains a well (199) into which a semen sample (200) is deposited. Upper piece (191) includes a recessed window (1 13), a button (160) and a rotatable knob (150). Knob (150) and button (160) are shaped such that knob (150) cannot be rotated until button (160) has beer depressed.
In Figure 10, the internal components of upper piece * 191) are shown in an exploded view. Upper piece (191 ) is formed from a top piece (192) which engages a seating (193). On the bottom of button (160) is a needle (168) and, when button (160) is operated, needle (168) pierces reservoir (165) which, prior to operation, contains a solution (140) of EBSS supplemented with 0.88mg/ml hyaluronic acid and 0.45% BSA. Reservoir (165) sits in plastic housing (166), which has a neck portion (1 15) and a head portion (120). The side of neck (1 15) contains a hole (130) which engages the tube portion (186) of test strip assembly (180). The base of head portion (120) is covered by a circular nylon mesh (121) formed from 0.15mm strands spaced by 0.25mm. In the assembled device (1 10), mesh (121) is in contact with sample (200) within well (199). Knob (150) is attached via a rack and pinion mechanism to plunger (155) which, prior to use, passes through tube ( 186) and towards hole (130). Seating ( 193) contains a battery (194) which powers heat source (170). When assembled, heat source (170) surrounds neck (1 15) circumferentially, except in the region of hole (130).
Exploded and assembled views of test strip assembly (180) are shown in Figure 1 1. In the assembled device (1 10), tubular portion ( 186) communicates directly with hole (130) and, prior to use, plunger ( 155) engages and fills tube (186), thereby preventing liquid flow therethrough. As plunger (155) is withdrawn by operation of knob ( 150) in the direction of the arrow in Figure 1 1 , tube (186) opens to form, together with hole ( 130), an outlet port (135) through which liquid can flow. Tube ( 186) and plunger (155) therefore operate in the manner of syringe. Liquid flows through tube ( 186) into the capillary space between clear plastic housings ( 181a; 181b) and passes under a pad (182) containing dehydrated gold-tagged murine anti-CD59. As liquid passes pad (182), the antibody is re-hydrated and can pass into the liquid, where it is able to bind to spermatozoa. The liquid continues to flow towards and into nitrocellulose strip ( 183), aided by a wick ( 188). The pore size of strip (183) is too small to allow the spermatozoa to enter, so they are captured at its entrance (184). Antibody can bind captured spermatozoa at entrance ( 184) and form a pink line. Any free antibody continues to flow until it is captured downstream at a line (185) of immobilised anti-mouse antibody.
The device is used as illustrated in figures 12 to 16:
- In figure 12, a semen sample (200; e.g. obtained by masturbation) is placed into lower piece (190) and collects in well (199) whilst lower piece (190) rests on a flat surface.
- After 30 minutes, upper piece (191) is assembled with lower piece (190) as shown in figure 13, to form device (1 10).
- Button (160) is then depressed, as shown in figure 14. This releases solution (140) and also activates heat source (170), bringing the temperature of solution (140) to 37°C. - After around 30 minutes, to allow entry of sperm into solution (140) and also temperature equilibration, LED (116) ndicates that knob (150) should be rotated, as in figure 15.
- This withdraws plunger (155) and allows motile sperm from sample (200) which have swum into medium (140) to pass into the tube portion (186) of test strip (180). The solution (140) flows through the test strip (180) by capillary action towards wick (188).
Sperm in the solution are retained at the entrance (184) of nitrocellulose strip (183). Free gold-tagged antibody continues to flow until it is captured downstream at a line (185) of immobilised anti-mouse antibody. The line at (184) in figure 16 indicates a positive result. The line at (185) indicates that the test has operated correctly.
It will be understood that the invention has been described by way of example only and modifications may be made whilst remaining within the scope and spirit of the invention.

Claims

1. A device for separating and detecting motile spermatozoa in a liquid sample, the device having:
- a sample separation vessel comprising: (a) a sample inlet port;
(b) a sample outlet port, which is initially closed;
(c) a sample separation medium into which motile spermatozoa in the sample can flow via the sample inlet port; and
(d) an actuator operable to open the sample outlet port, thereby allowing the sample separation medium to flow out of the vessel through the sample outlet port.
- spermatozoa detection means comprising:
(i) an application zone in communication with the outlet port; (ii) a detection zone, in which the presence of spermatozoa can be detected: and (iii) a reagent zone containing a reagent which is capable of reacting with spermatozoa to facilitate their detection in the detection zone, these zones being arranged to permit capillary flow of spermatozoa from the application zone to the detection zone.
2. The device of claim 1 , wherein the zones are arranged to permit capillary flow of spermatozoa from the application zone to the detection zone via the reagent zone.
3. The device of claim 1 or claim 2, wherein the detection zone is a spermatozoa-trapping zone capable of immobilising spermatozoa, and the reagent zone is a labelling zone containing a label capable of binding to spermatozoa.
4. The device of any preceding claim, wherein the vessel additionally comprises (e) a second actuator, operable to allow the separation medium to come into communication with a sample via the inlet port.
5. The device of claim 3 or claim 4, wherein the trapping zone is porous with a pore size such that free label can flow therethrough, whereas label which is bound to spermatozoa cannot.
6. The device of claim 3, claim 4 or claim 5, wherein the detection means includes a zone downstream of the detection zone which retains label which is not bound to spermatozoa.
7. The device of any preceding claim, wherein the application zone is non-fibrous.
8. The device of any preceding claim, wherein the device includes a temperature sensor.
9. The device of claim 8, which includes its own heat source and, optionally, temperature regulation means.
10. A device for separating and detecting motile spermatozoa in a liquid sample, the device having:
- a sample separation vessel comprising:
(a) a sample inlet port;
(b) a sample outlet port, which is initially closed;
(c) a sample separation medium into which motile spermatozoa in the sample can flow via the sample inlet port; and
(d) an actuator operable to open the sample outlet port, thereby allowing the sample separation medium to flow out of the vessel through the sample outlet port.
- spermatozoa detection means comprising:
(i) an application zone in communication with the outlet port; (ii) a trapping zone capable of immobilising spermatozoa; and
(iii) a labelling zone containing a label capable of binding to spermatozoa, these zones being arranged to permit capillary flow of spermatozoa from the application zone to the trapping zone.
1 1. A device substantially as hereinbefore described with reference to the accompanying drawings.
12. A device for separating and/or detecting spermatozoa, wherein sperm flow by capillary action takes place through non-fibrous material.
13. A device for separating and/or detecting motile and non-motile spermatozoa, wherein the device includes a temperature sensor, a heat source and, optionally, temperature regulation means.
PCT/GB2001/000654 2000-02-16 2001-02-16 Devices for motile sperm separation WO2001060968A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AU3387201A AU3387201A (en) 2000-02-16 2001-02-16 Devices for motile sperm separation
EP01905902A EP1255810B1 (en) 2000-02-16 2001-02-16 Device for separating and detecting motile spermatozoa
AT01905902T ATE283913T1 (en) 2000-02-16 2001-02-16 DEVICE FOR SEPARATING AND DETECTING MOBILE SPERMATOZOA
CA002399993A CA2399993A1 (en) 2000-02-16 2001-02-16 Devices for motile sperm separation
JP2001560340A JP4091767B2 (en) 2000-02-16 2001-02-16 Device for separating moving sperm
US10/203,318 US7179641B2 (en) 2000-02-16 2001-02-16 Device for motile sperm separation
DE60107538T DE60107538T2 (en) 2000-02-16 2001-02-16 DEVICE FOR DISCONNECTING AND DETECTING MOVABLE SPERMATOZOES
AU2001233872A AU2001233872B2 (en) 2000-02-16 2001-02-16 Devices for motile sperm separation
US11/324,257 US20060110821A1 (en) 2000-02-16 2006-01-04 Devices for motile sperm separation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003596.4A GB0003596D0 (en) 2000-02-16 2000-02-16 Sperm separation
GB0003596.4 2000-02-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/080,928 Division US20050158700A1 (en) 2000-02-16 2005-03-16 Devices for motile sperm separation

Publications (1)

Publication Number Publication Date
WO2001060968A1 true WO2001060968A1 (en) 2001-08-23

Family

ID=9885741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/000654 WO2001060968A1 (en) 2000-02-16 2001-02-16 Devices for motile sperm separation

Country Status (10)

Country Link
US (2) US7179641B2 (en)
EP (1) EP1255810B1 (en)
JP (1) JP4091767B2 (en)
AT (1) ATE283913T1 (en)
AU (2) AU2001233872B2 (en)
CA (1) CA2399993A1 (en)
DE (1) DE60107538T2 (en)
ES (1) ES2234809T3 (en)
GB (1) GB0003596D0 (en)
WO (1) WO2001060968A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004053465A2 (en) * 2002-12-09 2004-06-24 Advanced Fluidix Laboratories, Llc Male fertility assay method and device
GB2447417A (en) * 2007-03-14 2008-09-17 Farhang Abed Apparatus and method for separating motile sperm
WO2009043393A1 (en) * 2007-09-25 2009-04-09 Nanorepro Gmbh Fertility test
EP2682747A1 (en) * 2012-07-02 2014-01-08 ZECH, Josef Device for spematozoa selection
US8993310B2 (en) 2009-03-03 2015-03-31 Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) Device for diagnosis of physiologic status and/or selection of the best spermatozoa of a semen sample based on chemotaxis, and procedure of use thereof
WO2015077333A1 (en) 2013-11-20 2015-05-28 Brigham And Women's Hospital , Inc. System and method for sperm sorting
US9663755B2 (en) 2013-11-19 2017-05-30 The Governing Council Of The University Of Toronto Apparatus and methods for sperm separation
US10417481B2 (en) 2015-06-22 2019-09-17 The Brigham And Women's Hospital, Inc. Home evaluation of the quality of semen samples
US11352597B2 (en) 2015-09-28 2022-06-07 My123Baby Medical Limited Medical device for the selective separation of a biological sample
US11701655B2 (en) 2013-05-03 2023-07-18 Motilitycount Aps Device for analysis of cellular motility

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1672977A4 (en) * 2003-09-25 2008-03-12 Yeda Res & Dev Apparatus and methods for selecting capacitated spermatozoa and uses thereof
US9157063B2 (en) * 2007-01-16 2015-10-13 Texas Tech University System Method and apparatus for gender selection based on pH
US9168028B2 (en) * 2007-10-23 2015-10-27 Lotus Bio (Nymphaea) Ltd Cartridge for a biological sample
WO2009116051A1 (en) * 2008-03-20 2009-09-24 Tidhar Zanbar Method and kit for diagnosis of male fertility
JP2010004770A (en) * 2008-06-25 2010-01-14 Yuji Tsuji Device for sperm inspection
EP2421360B1 (en) * 2009-04-22 2014-05-07 Lotus Bio (Nymphaea) Ltd. A sperm separation system
US8828329B2 (en) 2010-10-01 2014-09-09 Church & Dwight, Co., Inc. Electronic analyte assaying device
EP2756074B1 (en) 2011-09-14 2018-11-07 Taipei Medical University Microfluidic chips for acquiring sperms with high motility, productions and applications thereof
WO2018140999A1 (en) 2017-01-31 2018-08-09 Genea Ip Holdings Pty Limited Method and system for processing a biological sample
KR102095267B1 (en) * 2018-10-22 2020-03-31 한국항공대학교산학협력단 Gravity-based motile sperm sorting device and the sorting method
WO2024107875A1 (en) * 2022-11-15 2024-05-23 Reprovantage Laboratories Sperm separation system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539628A1 (en) * 1983-01-25 1984-07-27 Fondation Rech Hormonologie Method for separating motile cells, especially motile spermatozoa, as well as a device for implementing this method
SU1486163A1 (en) * 1987-05-15 1989-06-15 Kubansk Selskokhozyajst Inst Method of separating spermia by mobility
US5866354A (en) * 1996-12-16 1999-02-02 The State Of Oregon Acting By And Through The State Of Board Of Higher Education On Behalf Of Oregon State University Method for measuring mobility of sperm
US5908380A (en) * 1998-01-12 1999-06-01 Zavos; Panayiotis M. Compartmentalized Zavos sperm swim-up column

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4381699A (en) * 1998-06-17 2000-01-05 Genosis, Inc. Method and kit for the detection of male infertility
GB9817795D0 (en) * 1998-08-14 1998-10-14 Genosis Inc A method and device for separation and detection of spermatozoa in a sample

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539628A1 (en) * 1983-01-25 1984-07-27 Fondation Rech Hormonologie Method for separating motile cells, especially motile spermatozoa, as well as a device for implementing this method
SU1486163A1 (en) * 1987-05-15 1989-06-15 Kubansk Selskokhozyajst Inst Method of separating spermia by mobility
US5866354A (en) * 1996-12-16 1999-02-02 The State Of Oregon Acting By And Through The State Of Board Of Higher Education On Behalf Of Oregon State University Method for measuring mobility of sperm
US5908380A (en) * 1998-01-12 1999-06-01 Zavos; Panayiotis M. Compartmentalized Zavos sperm swim-up column

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section PQ Week 199013, Derwent World Patents Index; Class P32, AN 1990-097584, XP002155746 *

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004053465A2 (en) * 2002-12-09 2004-06-24 Advanced Fluidix Laboratories, Llc Male fertility assay method and device
WO2004053465A3 (en) * 2002-12-09 2004-11-11 Advanced Fluidix Lab Llc Male fertility assay method and device
US6929945B2 (en) 2002-12-09 2005-08-16 Advanced Fluidix Laboratories Llc Male fertility assay method and device
US7108966B2 (en) 2002-12-09 2006-09-19 Pria Diagnostics, Llc Male fertility assay method and device
GB2447417A (en) * 2007-03-14 2008-09-17 Farhang Abed Apparatus and method for separating motile sperm
WO2009043393A1 (en) * 2007-09-25 2009-04-09 Nanorepro Gmbh Fertility test
US8993310B2 (en) 2009-03-03 2015-03-31 Consejo Nacional De Investigaciones Cientificas Y Technicas (CONICET) Device for diagnosis of physiologic status and/or selection of the best spermatozoa of a semen sample based on chemotaxis, and procedure of use thereof
EP2682747A1 (en) * 2012-07-02 2014-01-08 ZECH, Josef Device for spematozoa selection
WO2014006043A3 (en) * 2012-07-02 2014-02-27 Josef Zech Device for spematozoa selection
US9606099B2 (en) 2012-07-02 2017-03-28 Josef Zech Selection device
US11701655B2 (en) 2013-05-03 2023-07-18 Motilitycount Aps Device for analysis of cellular motility
US9663755B2 (en) 2013-11-19 2017-05-30 The Governing Council Of The University Of Toronto Apparatus and methods for sperm separation
EP3071704A4 (en) * 2013-11-20 2017-10-04 Brigham and Women's Hospital, Inc. System and method for sperm sorting
WO2015077333A1 (en) 2013-11-20 2015-05-28 Brigham And Women's Hospital , Inc. System and method for sperm sorting
US10422737B2 (en) 2013-11-20 2019-09-24 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US11982610B2 (en) 2013-11-20 2024-05-14 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US11009444B2 (en) 2013-11-20 2021-05-18 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US11946846B2 (en) 2013-11-20 2024-04-02 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
EP4039817A1 (en) * 2013-11-20 2022-08-10 Brigham and Women's Hospital, Inc. System and method for sperm sorting
EP4269984A3 (en) * 2013-11-20 2024-02-07 Brigham and Women's Hospital, Inc. System and method for sperm sorting
US11709122B2 (en) 2013-11-20 2023-07-25 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US11788943B2 (en) 2013-11-20 2023-10-17 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US11841309B2 (en) 2013-11-20 2023-12-12 The Brigham And Women's Hospital, Inc. System and method for sperm sorting
US10417481B2 (en) 2015-06-22 2019-09-17 The Brigham And Women's Hospital, Inc. Home evaluation of the quality of semen samples
US10977477B2 (en) 2015-06-22 2021-04-13 The Brigham And Women's Hosptial, Inc. Home evaluation of the quality of semen samples
US11352597B2 (en) 2015-09-28 2022-06-07 My123Baby Medical Limited Medical device for the selective separation of a biological sample

Also Published As

Publication number Publication date
JP2003523194A (en) 2003-08-05
ES2234809T3 (en) 2005-07-01
EP1255810B1 (en) 2004-12-01
AU3387201A (en) 2001-08-27
DE60107538D1 (en) 2005-01-05
US20030096395A1 (en) 2003-05-22
JP4091767B2 (en) 2008-05-28
US20060110821A1 (en) 2006-05-25
CA2399993A1 (en) 2001-08-23
GB0003596D0 (en) 2000-04-05
EP1255810A1 (en) 2002-11-13
DE60107538T2 (en) 2005-11-10
AU2001233872B2 (en) 2004-10-07
US7179641B2 (en) 2007-02-20
ATE283913T1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
US20060110821A1 (en) Devices for motile sperm separation
AU2001233872A1 (en) Devices for motile sperm separation
US20220280141A1 (en) Method and apparatus for collecting and preparing biological samples for testing
US20230243809A1 (en) Device for whole blood separation
EP1104454B1 (en) Separation and detection of spermatozoa
CN100498335C (en) In-line test device and methods of use
US4632901A (en) Method and apparatus for immunoassays
US4665034A (en) Device for performing qualitative enzyme immunoassays
US20040019301A1 (en) Integrated confirmation sample in a body fluid test device and method of using
RU2706710C1 (en) Analysis device
FI60935C (en) FOERFARANDE FOER KONCENTRERING OCH RENING AV ETT URIN- OCH SERUMPROV FOER BESTAEMNING AV HCG ELLER DESS BETA-UNDERENHET IMMUNOLOGISKT OCH I FOERFARANDET ANVAENDBAR ANORDNING
JP2007511768A (en) Fluid sample analyzer with sealable sample storage reservoir
HU206918B (en) Analytical detecting instrument
EP0293447A1 (en) A device and method for self contained solid phase immunodiffusion assay.
US20080112847A1 (en) Collecting and testing device and method of use
KR20010108273A (en) Analyzing strip having a fluid cell and a method of analyzing a sample
US20050158700A1 (en) Devices for motile sperm separation
US20120149093A1 (en) Method and Apparatus for Automating Chemical and Biological Assays
NO860937L (en) DIAGNOSTICS FOR ASSAY PROVISIONS.
JPH02170051A (en) Liquid inspection instrument
Talbot et al. Capillary blood collection tubes may affect serum progesterone

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001233872

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2399993

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 560340

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001905902

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10203318

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001905902

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2001905902

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001233872

Country of ref document: AU